Mumbai, June 26 -- The board of Ipca Laboratories at its meeting held on 26 June 2026 has approved the scheme of amalgamation of Krebs Biochemicals & Industries (Transferor Company) with the company (Transferee

Company) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013.

Published by HT Digital Content Services with permission from Capital Market....